We audited the effect of introducing HIV opt-out in a genitourinary medicine clinic in central London, UK. We found that opt-out increased the rate at which HIV testing was offered to low-risk patients and that more tests were done.
BrownAE, SadlerKE, TomkinsSE, Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect2004;80:159–66
2.
Health Protection Agency. Testing Times. HIV and other Sexually Transmitted Infection in the United Kingdom: 2007. London: Centre for Infection, Health Protection Agency, 2007
3.
PalellaFJJr, Deloria-KnollM, ChmielJS, Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med2003;138:620–6
4.
ChadbornTR, BasterK, DelpechV, No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002). AIDS2005;19:513–20
5.
EggerM, MayM, CheneG, Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet2002;360:119–29
6.
QuinnTC, WawerMJ, SewankamboN, Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med2000;342:921–9
7.
StanleyB, FraserJ, CoxNH. Uptake of HIV screening in genitourinary medicine after change to “opt-out” consent. Br Med J2003;326:1174
8.
MahtoM, HigginsSP. Increased uptake of HIV screening following introduction of “opt out” testing and results by telephone. Sex Transm Infect2004;80:156
9.
ShaguftaZ, MahtoM. Uptake of HIV testing in a genitourinary medicine clinic following opt-out screening method and uptake rate by individual clinicians. Int J STD AIDS2007;18:650
10.
Department of Health. The National Strategy for Sexual Health and HIV. London, Department of Health, 2001
11.
MunroHL, LowndesCM, DanielsDG, National study of HIV testing in men who have sex with men attending genitourinary clinics in the United Kingdom. Sex Transm Infect2008;84:265–70
